GoodRx: timeline
Every dated event on file, newest first: history, results, dividends, splits, index changes, insider trades, layoffs and recalls, each with its source.
49 events
On the market-cap history; source: Market-cap history on value.today.
Point at a marker under the line to see the event. Green: good news by its nature (a raise, an index entry), orange: bad (a cut, a layoff), grey: neither.
2026
- Oct 27, 2026Financial statements withdrawn
Earlier financial statements or an audit report can no longer be relied on.
Notable 8-K events · source: SEC EDGAR (Form 8-K)
- Aug 5, 2026Results released
Form 8-K filed 05 Aug 2026
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
- May 6, 2026Results released
Form 8-K filed 06 May 2026
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
- Mar 14, 2026Auditor changed
The company's auditor resigned, was dismissed or a new one was engaged.
Notable 8-K events · source: SEC EDGAR (Form 8-K)
- Feb 26, 2026Annual report filed (Form 10-K)
For the year to 31 Dec 2025
Annual reports · source: SEC EDGAR (10-K, 20-F, 40-F)
- Feb 25, 2026Results released
Form 8-K filed 25 Feb 2026
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
2025
- Nov 4, 2025Results released
Form 8-K filed 04 Nov 2025
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
- Oct 9, 2025Trading halted on its exchange (volatility pause)
Resumed 09 Oct 2025 16:33 UTC
Trading halts · source: Nasdaq Trader halt list
- Aug 6, 2025Results released
Form 8-K filed 06 Aug 2025
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
- May 7, 2025Results released
Form 8-K filed 07 May 2025
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
- Feb 27, 2025Results released
Form 8-K filed 27 Feb 2025
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
- Feb 27, 2025Annual report filed (Form 10-K)
For the year to 31 Dec 2024
Annual reports · source: SEC EDGAR (10-K, 20-F, 40-F)
- 2025Record revenue of $797 million
FY2025, the highest of the 8 years on record.
Company history · source: Financial years
2024
- Nov 7, 2024Results released
Form 8-K filed 07 Nov 2024
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
- Aug 8, 2024Results released
Form 8-K filed 08 Aug 2024
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
- May 9, 2024Results released
Form 8-K filed 09 May 2024
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
- Feb 29, 2024Results released
Form 8-K filed 29 Feb 2024
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
- Jan 10, 2024Results released
Form 8-K filed 10 Jan 2024
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
2023
- Nov 30, 20231 insider bought $982,411 of shares on the market
Open-market purchases between 16 Nov and 30 Nov 2023
Insider buying and large selling · source: SEC Forms 4 and 5
- Nov 9, 2023Results released
Form 8-K filed 09 Nov 2023
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
- Aug 9, 2023Results released
Form 8-K filed 09 Aug 2023
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
- May 10, 2023Results released
Form 8-K filed 10 May 2023
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
- Apr 25, 2023Results released
Form 8-K filed 25 Apr 2023
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
- Feb 28, 2023Results released
Form 8-K filed 28 Feb 2023
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
2022
- Nov 8, 2022Results released
Form 8-K filed 08 Nov 2022
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
- Aug 31, 2022
- Aug 30, 2022Restructuring plan: 140 employees
(the “Company”, “we”, “us” or “our”) approved a reduction in force involving approximately 140 employees of its indirect wholly owned subsidiary GoodRx, Inc., representing approximately 16% of GoodRx,
Layoffs · source: SEC filing (8-K Item 2.05)
- Aug 8, 2022Results released
Form 8-K filed 08 Aug 2022
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
- May 9, 2022Results released
Form 8-K filed 09 May 2022
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
- Feb 28, 2022Results released
Form 8-K filed 28 Feb 2022
Results releases · source: SEC EDGAR (Form 8-K, item 2.02)
Share price moves are worked out where the site has the listing's daily prices from the exchange itself: India (NSE), Taiwan (TWSE, TPEx), Brazil (B3), Poland (GPW), Russia (MOEX), Hong Kong (HKEX) and Sri Lanka (CSE). US listings have no daily price source on the site yet.
Sources: company history from Wikidata, SEC EDGAR, GLEIF and the site's own tables; results releases from SEC EDGAR (Form 8-K, item 2.02); annual reports from SEC EDGAR (10-K, 20-F, 40-F); insider buying and large selling from SEC Forms 4 and 5; notable 8-k events from SEC EDGAR (Form 8-K); layoffs from State WARN notices and SEC 8-K item 2.05; trading halts from Nasdaq Trader halt list. Recurring events go back 15 years; the company's history is shown in full. Dividends appear when the amount per share changed; insider selling when a month's sales reach $10 million or 0.01% of the company.